Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 169

Bloom Energy to sprout in public markets

E.ON-backed fuel cell system producer Bloom Energy has reportedly filed for an initial public offering, one likely to value it at less than its previous $2.9bn valuation.

Oct 10, 2016

Obalon blows up $75m IPO

The gastric balloon developer has gone public, after raising more than $70m in debt and equity from investors including Bader Sultan & Bros and AmorePacific.

Oct 7, 2016

Snap quickens pace to 2017 IPO

Snap, formerly known as Snapchat and backed by Alibaba, Tencent and Yahoo, is preparing an offering that could value it at $25bn and take place as early as March.

Oct 7, 2016

Nutanix processes flotation

The cloud enterprise platform, backed by Sapphire Ventures, is set to make its debut on Nasdaq today after securing nearly $238m in an initial public offering yesterday.

Sep 30, 2016

ForeScout Technologies explores flotation

Itochu and Intel-backed cybersecurity company ForeScout has entered talks with investment banks to underwrite an IPO that could value it at up to $1bn.

Sep 27, 2016

Nokia exits Gridsum in $87m IPO

China-based data analysis software producer Gridsum Holding has floated in the US, giving exits to Nokia Growth Partners and Disney affiliate Steamboat Ventures.

Sep 27, 2016

Apptio manages $96m IPO

The business management software producer floated above its range in an offering that allowed Cisco to exit, and which could reach $110m in size.

Sep 26, 2016

Novan cleans up in $45m IPO

The Malin-backed dermatology treatment developer floated at the bottom of its range, but is currently 65% up after its first day of trading.

Sep 22, 2016

Uzabase to touch down on public markets

The company database and news app operator, backed by GMO, Yahoo Japan, Itochu and Kodansha, will float in its home country of Japan next month.

Sep 19, 2016

Crispr plays it cool with IPO filing

Existing backer Bayer will invest $35m through a private placement alongside an initial public offering in which the gene editing company is initially looking to raise $90m.

Sep 13, 2016
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here